Showing results (411-420 of 554) with videos related to

Sort By:
Pageof 56
Cancer Chemotherapy and Pharmacology|January 15, 2013
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancerEmmanuel S Antonarakis, Elisabeth I Heath, Edwin M Posadas, et al.
JCO Precision Oncology|July 12, 2022
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting TherapiesAmado J Zurita, Ryon P Graf, Guillermo Villacampa, et al.
The Prostate|February 26, 2021
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trialEugene Shenderov, Karim Boudadi, Wei Fu, et al.
European Urology|July 7, 2020
A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide CohortsMark C Markowski, Hao Wang, Rana Sullivan, et al.
Oncogene|September 29, 2020
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitorsYezi Zhu, Susan L Dalrymple, Ilsa Coleman, et al.
JCO Oncology Practice|February 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing TestingMadelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient GroupsAllison Makovec, Ava P Gustafson, Nishant Gandhi, et al.
The Prostate|May 28, 2015
A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determinationChanning J Paller, Michelle A Rudek, Xian C Zhou, et al.
The Prostate|March 24, 2023
Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancerSydney A Caputo, Madeline Hawkins, Ellen B Jaeger, et al.
Genes, Chromosomes & Cancer|November 10, 2019
Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancerSantosh Gupta, Daniel H Hovelson, Gabor Kemeny, et al.
Pageof 56